Author

Cathy Lee Mendelsohn

Columbia UniversityORCID 0000-0002-4026-4073Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Adam K. AragakiiD· 1 shared Akinaru Yamamoto· 1 shared Ali G. GharaviiD· 1 shared Alyssa G. ArbuisoiD· 1 shared Andrés MatosoiD· 1 shared Anne E. GelleriD· 1 shared Armine Smith· 1 shared Atlas Kahn· 1 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam K. AragakiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Epithelial to mesenchymal transition and M2 macrophages drive aggressiveness in murine and human sarcomatoid urothelial carcinoma.

Yujiro Hayashi, Roy Elias, Eugene Douglass, Akinaru Yamamoto, Matthew Schuler, Mingxiao Feng, Ekatherina Y. Batourina, Anne E. Geller, Woonyoung Choi, Gabriela Colocho, Alyssa G. Arbuiso, Samuel Jin, Adam K. Aragaki, Charles Ruland, Stanley Rapiey, , Burles Avner Johnson

The paper develops a murine model of sarcomatoid urothelial carcinoma (SUC) and finds it shares molecular and immunological features with human SUC, suggesting its use for therapeutic research.

bioRxiv · Oct 2, 2026 · PreprintCancer Biology

Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy

Mathieu Rouanne, Noah Chen, Dylan L. Mariuzza, Zaofeng Yang, Fangda Li, Kenia de los Santos, Thomas M. Savage, Rosa L. Vincent, Cathy Lee Mendelsohn, Tal Danino, Nicholas Arpaia

This study shows engineered E. coli expressing CXCL13 enhances bladder cancer immunotherapy when combined with PD-1 blockade by promoting tumor-specific antibody responses.

Science Translational Medicine · Jul 22, 2026Peer-reviewedImmunology

Interstitial Cystitis: a phenotype and rare variant exome sequencing study

Joshua E. Motelow, Ayan Malakar, Sarath Babu Krishna Murthy, Miguel Verbitsky, Atlas Kahn, Elicia A. Estrella, Wanqing Shao, Louis M. Kunkel, Madelyn Wiesenhahn, Jaimee Beckett, Natasha Harris, Richard Lee, R. M. Adam, Kamil E. Barbour, Hakon H. Hakonarson, , Catherine A. Brownstein

This study uses exome sequencing to identify genetic associations with interstitial cystitis/bladder pain syndrome, finding new links and extending known associations.

EBioMedicine · Feb 18, 2026Peer-reviewedGenetic & Genomic Medicine